Yu Meng
Impact in
-
- Ferroptosis and cancer prognosis
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ferroptosis and cancer prognosis 5
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 1
- Cancer-related gene regulation 1
- Co-authors
- Guangtong Deng (6 shared papers)Furong Zeng (6 shared papers)Yuming Sun (5 shared papers)Xiang Chen (3 shared papers)Jiayuan Le (2 shared papers)Daishi Li (3 shared papers)Qian Zhou (2 shared papers)Lei Yao (3 shared papers)
In The Last Decade
Yu Meng
8 papers receiving 560 citations
Yu Meng's Hit Papers
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 330
- Cancer Research 149
- Molecular Biology 245
- Immunology 57
- Oncology 50
Countries citing papers authored by Yu Meng
This map shows the geographic impact of Yu Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Meng more than expected).
Fields of papers citing papers by Yu Meng
This network shows the impact of papers produced by Yu Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Meng. The network helps show where Yu Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies Hit paper breakdown → | 2024 | 438 |
| 2 | 2023 | 37 | |
| 3 | Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity Hit paper breakdown → | 2025 | 28 |
| 4 | 2024 | 24 | |
| 5 | 2022 | 19 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 4 | |
| 8 | 2025 | 2 | |
| 9 | 2025 | 0 |
About Yu Meng
Yu Meng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Immunology, Dermatology and Health, Toxicology and Mutagenesis, having authored 9 papers that have together received 562 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (3 papers), Heavy Metal Exposure and Toxicity (1 paper), Cancer, Lipids, and Metabolism (1 paper), Epigenetics and DNA Methylation (1 paper), Cancer-related gene regulation (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Asthma and respiratory diseases (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (330 citations), Cancer Research (149 citations), Molecular Biology (245 citations), Immunology (57 citations) and Oncology (50 citations). Yu Meng has collaborated with scholars based in China and Canada. Frequent co-authors include Guangtong Deng, Furong Zeng, Yuming Sun, Xiang Chen, Jiayuan Le, Daishi Li, Qian Zhou, Lei Yao, Yating Dian and Siyuan Tang. Their work appears in journals such as Signal Transduction and Targeted Therapy, Advanced Healthcare Materials, Cell Reports Medicine, Redox Biology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.